Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
4,900,401
-
Shares change
-
+494,415
-
Total reported value, excl. options
-
$51,286,090
-
Value change
-
+$5,925,931
-
Number of buys
-
33
-
Number of sells
-
-9
-
Price
-
$10.46
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2019
50 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q3 2019.
XBiotech Inc. - Common Shares, no par value (XBIT) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,900,401 shares
of 33,289,095 outstanding shares and own 14.72% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,268,899 shares), VANGUARD GROUP INC (1,090,484 shares), BAKER BROS. ADVISORS LP (521,327 shares), Sofinnova Investments, Inc. (358,663 shares), STATE STREET CORP (351,584 shares), GEODE CAPITAL MANAGEMENT, LLC (303,932 shares), NORTHERN TRUST CORP (231,702 shares), EAM Investors, LLC (63,108 shares), 683 Capital Management, LLC (60,000 shares), and Bank of New York Mellon Corp (58,099 shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.